Cavanaugh P G, Jia L, Zou Y, Nicolson G L
Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Breast Cancer Res Treat. 1999 Aug;56(3):203-17. doi: 10.1023/a:1006209714287.
We previously found that breast cancer cell transferrin receptor expression and proliferative response to transferrin often correlated with metastatic capability. To further explore this, we transfected mammary tumor cells with a cDNA coding for the transferrin receptor and examined the effects of its overexpression on various cellular properties. A human transferrin receptor expression plasmid was made by excising the cDNA for the receptor from pcDTR1 and ligating it into the multiple cloning site of pcDNAINeo. The resulting construct was transfected into the poorly metastatic rat MTLn2 line that expresses low endogenous levels of rat transferrin receptor, and transfection-induced receptor expression was ascertained using antibodies specific for the human protein. Approximately 50% of the initial geneticin-resistant transfected MTLn2 cells overexpressed human transferrin receptor protein. High expressors were further isolated by four sequential FACS sorts. The final cell population expressed approximately 3-7 times more cell surface transferrin receptor than did vector transfected controls. Both lines proliferated at the same rate in normal (medium plus 5% FBS) culture conditions. However, in serum-free conditions, the transferrin receptor overexpressor cells displayed a pronounced proliferative response to transferrin whereas the control line did not. When injected into the mammary fat pads of female nude mice, cells from both lines formed micrometastases to the lung that were specifically visualized by immunohistochemical staining of rat cytokeratin 17. This revealed that the transferrin receptor transfected line formed larger lesions of this nature than did cells from the vector transfected controls. When injected into the tail vein of female nude mice, the transferrin receptor overexpressors likewise formed gross lung metastases of remarkably greater size than did the vector only transfectants. Overexpression of cell surface human transferrin receptor on MTLn2 cells appeared to affect their in vitro growth response to transferrin and their ability to grow at a secondary site in vivo.
我们之前发现,乳腺癌细胞转铁蛋白受体的表达以及对转铁蛋白的增殖反应常常与转移能力相关。为了进一步探究这一点,我们用编码转铁蛋白受体的cDNA转染乳腺肿瘤细胞,并检测其过表达对各种细胞特性的影响。通过从pcDTR1中切除受体的cDNA并将其连接到pcDNAINeo的多克隆位点,构建了一个人转铁蛋白受体表达质粒。将所得构建体转染到转移能力较差、内源性大鼠转铁蛋白受体表达水平较低的大鼠MTLn2细胞系中,使用针对人蛋白的特异性抗体确定转染诱导的受体表达情况。最初对遗传霉素有抗性的转染MTLn2细胞中约50%过表达人转铁蛋白受体蛋白。通过四轮连续的荧光激活细胞分选术进一步分离高表达细胞。最终的细胞群体表达的细胞表面转铁蛋白受体比载体转染的对照细胞多约3至7倍。在正常(培养基加5%胎牛血清)培养条件下,两个细胞系的增殖速率相同。然而,在无血清条件下,转铁蛋白受体过表达细胞对转铁蛋白表现出明显的增殖反应,而对照细胞系则没有。当将两个细胞系的细胞注射到雌性裸鼠的乳腺脂肪垫中时,通过对大鼠细胞角蛋白17进行免疫组织化学染色可特异性观察到,两个细胞系的细胞都形成了肺部微转移灶。这表明,转铁蛋白受体转染细胞系形成的此类病灶比载体转染对照细胞形成的病灶更大。当将细胞注射到雌性裸鼠的尾静脉中时,转铁蛋白受体过表达细胞同样形成了比仅转染载体的细胞大得多的明显肺转移灶。MTLn2细胞表面人转铁蛋白受体的过表达似乎影响了它们在体外对转铁蛋白的生长反应以及在体内继发部位生长的能力。